Braeden K. Ego

ORCID: 0000-0003-3018-1423
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CRISPR and Genetic Engineering
  • RNA and protein synthesis mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Bacterial Genetics and Biotechnology
  • Neurogenetic and Muscular Disorders Research
  • Calcium signaling and nucleotide metabolism
  • Immune Cell Function and Interaction
  • Cellular transport and secretion
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Immunodeficiency and Autoimmune Disorders
  • Phagocytosis and Immune Regulation
  • Genomics and Rare Diseases
  • Insect Resistance and Genetics
  • Endoplasmic Reticulum Stress and Disease
  • Neuroinflammation and Neurodegeneration Mechanisms

Stanford University
2018-2023

Boston University
2023

Harvard University
2023

Abstract Pooled CRISPR-Cas9 screens are a powerful method for functionally characterizing regulatory elements in the non-coding genome, but off-target effects these experiments have not been systematically evaluated. Here, we investigate Cas9, dCas9, and CRISPRi/a activity essential elements. The sgRNAs with largest genome-scale CTCF loop anchors K562 cells were single guide RNAs (sgRNAs) that disrupted gene expression near on-target anchor. Rather, had high that, while only weakly...

10.1038/s41467-019-11955-7 article EN cc-by Nature Communications 2019-09-06
Lindsay Rosenfeld Kimberly LeBlanc Anna Nagy Braeden K. Ego Maria T. Acosta and 95 more Margaret P Adam David R. Adams Raquel L. Alvarez Justin Alvey Laura M. Amendola Ashley Andrews Euan A. Ashley Carlos A. Bacino Güney Bademci Ashok Balasubramanyam Dustin Baldridge Jim Bale Michael J. Bamshad Deborah Barbouth Pınar Bayrak‐Toydemir Anita Beck Alan H. Beggs Edward M. Behrens Gill Bejerano Hugo J. Bellen Jimmy Bennett Beverly Berg-Rood Jonathan A. Bernstein Gerard T. Berry Anna Bican Stephanie Bivona Elizabeth Blue John Bohnsack Devon Bonner Lorenzo D. Botto Brenna Boyd Lauren C. Briere Elly Brokamp Gabrielle Brown Elizabeth A. Burke Lindsay C. Burrage Manish J. Butte Peter H. Byers William E. Byrd John C. Carey Olveen Carrasquillo Thomas Cassini Ta Chen Chang Sirisak Chanprasert Hsiao‐Tuan Chao Gary Clark Terra R. Coakley Laurel A. Cobban Joy D. Cogan Matthew Coggins F. Sessions Cole Heather A. Colley Cynthia M. Cooper Heidi Cope Rosario I. Corona William J. Craigen Andrew B. Crouse Michael L. Cunningham Precilla D’Souza Hongzheng Dai Surendra Dasari Joie Davis Jyoti G. Dayal Esteban C. Dell’Angelica Katrina M. Dipple Daniel Doherty Naghmeh Dorrani Argenia L. Doss Emilie D. Douine Laura Duncan Dawn Earl David J. Eckstein Lisa Emrick Christine M. Eng Marni J. Falk Elizabeth L. Fieg Paul G. Fisher Brent L. Fogel Irman Forghani William A. Gahl Ian Glass Bernadette Gochuico Pagé C. Goddard Rena A. Godfrey Katie Golden‐Grant Alana Grajewski Don Hadley Sihoun Hahn Meghan C. Halley Rizwan Hamid Kelly Hassey Nichole Hayes Frances A. High Anne Hing Fuki M. Hisama

Abstract Introduction The Undiagnosed Diseases Network (UDN), a clinical research study funded by the National Institutes of Health, aims to provide answers for patients with undiagnosed conditions and generate knowledge about underlying disease mechanisms. UDN evaluations involve collaboration between clinicians researchers go beyond what is possible in settings. While medical outcomes have been explored, this first formal assessment patient caregiver experience. Methods We invited...

10.1186/s13023-023-02695-5 article EN cc-by Orphanet Journal of Rare Diseases 2023-04-10

Abstract Background Over the past decade, human Interleukin 33 (hIL-33) has emerged as a key contributor to pathogenesis of numerous inflammatory diseases. Despite existence several commercial hIL-33 assays spanning multiple platform technologies, their ability provide accurate concentration measurements and differentiate between active (reduced) inactive (oxidized) in various matrices remains uncertain. This is especially true for lower sample volumes, with low concentrations, elevated...

10.1186/s12967-021-03189-3 article EN cc-by Journal of Translational Medicine 2021-12-01

Abstract Pooled CRISPR-Cas9 screens have recently emerged as a powerful method for functionally characterizing regulatory elements in the non-coding genome, but off-target effects these experiments not been systematically evaluated. Here, we conducted genome-scale screen essential CTCF loop anchors K562 leukemia cell line. Surprisingly, primary drivers of signal this were single guide RNAs (sgRNAs) with low specificity scores. After removing guides, found that there no critical growth. We...

10.1101/520569 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2019-01-18

Summary Thousands of proteins localize to the nucleus; however, it remains unclear which contain transcriptional effectors. Here, we develop HT-recruit - a pooled assay where protein libraries are recruited reporter, and their effects measured by sequencing. Using this approach, measure gene silencing activation for thousands domains. We find relationship between repressor function evolutionary age KRAB domains, discover Homeodomain strength is collinear with Hox genetic organization,...

10.1101/2020.09.09.288324 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2020-09-10
Coming Soon ...